• Explore /
  • Poster
  • / A pragmatic, single-arm clinical trial of a dose-adjustment algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy.

A pragmatic, single-arm clinical trial of a dose-adjustment algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy.

Abstract Poster

Authors

null

Gabriel A. Brooks

Dartmouth Cancer Center, Lebanon, NH

Gabriel A. Brooks , Heather Wright , Gregory H. Ripple , Manik A. Amin , Alexander D. Fuld , Sivraj Muralikrishnan , Elizabeth Boutin McGrath , Maureen G. Stannard , Lora L. Schofield , Sierra Lord-Halvorson , Grace R. Lachance , Tor D. Tosteson , Anna N.A. Tosteson , Konstantin H. Dragnev , Kathryn Cunningham Hourdequin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Real-World Data/Outcomes

Clinical Trial Registration Number

NCT04526886

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6608)

DOI

10.1200/JCO.2023.41.16_suppl.6608

Abstract #

6608

Poster Bd #

100

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer.

A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer.

First Author: Akshit Chitkara

First Author: Haeseong Park

First Author: Masato Nakamura

First Author: Wenjing Wang